Successful translation of fluorescence navigation during oncologic surgery: A consensus report

Journal of Nuclear Medicine

Volumn 57, Issue 1, 2016, Pages 144-150

  Rosenthal, Eben L ^a   Warram, Jason M ^b,c   De Boer, Esther ^b,d   Basilion, James P ^e   Biel, Merrill A ^f   Bogyo, Matthew ^g   Bouvet, Michael ^h   Brigman, Brian E ⁱ   Colson, Yolonda L ^j   DeMeester, Steven R ^k   Gurtner, Geoffrey C ^g   Ishizawa, Takeaki ^l   Jacobs, Paula M ^m   Keereweer, Stijn ⁿ   Liao, Joseph C ^o   Nguyen, Quyen T ^p   Olson, James M ^q,r   Paulsen, Keith D ^s   Rieves, Dwaine ^t   Sumer, Baran D ^u   Tweedle, Michael F ^v   Vahrmeijer, Alexander L ^w   Weichert, Jamey P ^x   Wilson, Brian C ^y,z   Zenn, Michael R ⁱ   Zinn, Kurt R ^c   Van Dam, Gooitzen M ^d   more..

^a STANFORD UNIVERSITY   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF MINNESOTA   (United States)

^g STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

ⁱ DUKE UNIVERSITY MEDICAL CENTER   (United States)

^j BRIGHAM AND WOMEN S HOSPITAL   (United States)

^k UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^l UNIVERSITY OF TOKYO   (Japan)

^m NATIONAL CANCER INSTITUTE   (United States)

ⁿ ERASMUS MEDICAL CENTER   (Netherlands)

^o STANFORD UNIVERSITY   (United States)

^p UNIVERSITY OF CALIFORNIA   (United States)

^q Fred Hutchinson Cancer Research Center   (United States)

^r SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^s DARTMOUTH MEDICAL SCHOOL   (United States)

^t NDA Partners LLC   (United States)

^u UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^v THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^w LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^x UNIVERSITY OF WISCONSIN MADISON   (United States)

^y UNIVERSITY HEALTH NETWORK   (Canada)

^z UNIVERSITY OF TORONTO   (Canada)

more..

Author keywords

Consensus report; Fluorescence guided surgery; ISIGS; Regulatory guidance

Indexed keywords

AMINOLEVULINIC ACID; ANTINEOPLASTIC AGENT; AVB 620; BEVACIZUMAB; BLZ 100; CETUXIMAB; CONTRAST MEDIUM; LUM 015; MDX 1201A 488; PANITUMUMAB; PROSTAFLUOR; UNCLASSIFIED DRUG;

ARTICLE; BRAIN TUMOR; BREAST CANCER; CANCER SURGERY; CONSENSUS DEVELOPMENT; DRUG SAFETY; DRUG TARGETING; ESOPHAGUS INJURY; FAMILIAL COLON POLYPOSIS; FLUORESCENCE GUIDED SURGERY; FLUORESCENCE IMAGING; FLUORESCENCE NAVIGATION; FOOD AND DRUG ADMINISTRATION; GLIOBLASTOMA; GLIOMA; GOLD STANDARD; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; HYPOPHYSIS ADENOMA; MEDICAL SOCIETY; MENINGIOMA; PRIORITY JOURNAL; PROSTATE CANCER; RECTUM CANCER; SARCOMA; SURGICAL TECHNIQUE; ADVERSE EFFECTS; BIOASSAY; COMPUTER ASSISTED SURGERY; CONSENSUS; DEVICES; GOVERNMENT REGULATION; NEOPLASMS; PATIENT SAFETY; PHASE 1 CLINICAL TRIAL (TOPIC); PROCEDURES; RESEARCH; TRANSLATIONAL RESEARCH; UNITED STATES;

CLINICAL TRIALS, PHASE I AS TOPIC; CONSENSUS; ENDPOINT DETERMINATION; GOVERNMENT REGULATION; HUMANS; NEOPLASMS; OPTICAL IMAGING; PATIENT SAFETY; RESEARCH REPORT; SURGERY, COMPUTER-ASSISTED; TRANSLATIONAL MEDICAL RESEARCH; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84958678106     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.115.158915     Document Type: Article

References (20)

1. Chambers KJ, Kraft S, Emerick K. Evaluation of frozen section margins in highrisk cutaneous squamous cell carcinomas of the head and neck. Laryngoscope. 2015;125:636-639.
2. Zarbo RJ, Hoffman GG, Howanitz PJ. Interinstitutional comparison of frozensection consultation: a College of American Pathologists Q-Probe study of 79,647 consultations in 297 North American institutions. Arch Pathol Lab Med. 1991;115:1187-1194.
3. Stummer W, Novotny A, Stepp H, Goetz C, Bise K, Reulen HJ. Fluorescenceguided resection of glioblastoma multiforme by using 5-aminolevulinic acidinduced porphyrins: a prospective study in 52 consecutive patients. J Neurosurg. 2000;93:1003-1013.
4. Stummer W, Pichlmeier U, Meinel T, et al. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol. 2006;7:392-401.
5. Day KE, Beck LN, Deep NL, Kovar J, Zinn KR, Rosenthal EL. Fluorescently labeled therapeutic antibodies for detection of microscopic melanoma. Laryngoscope. 2013;123:2681-2689.
6. Rosenthal EL, Kulbersh BD, Duncan RD, et al. In vivo detection of head and neck cancer orthotopic xenografts by immunofluorescence. Laryngoscope. 2006;116: 1636-1641.
7. van Dam GM, Themelis G, Crane LM, et al. Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-a targeting: first in-human results. Nat Med. 2011;17:1315-1319.
8. Kulbersh BD, Duncan RD, Magnuson JS, Skipper JB, Zinn K, Rosenthal EL. Sensitivity and specificity of fluorescent immunoguided neoplasm detection in head and neck cancer xenografts. Arch Otolaryngol Head Neck Surg. 2007;133: 511-515.
9. Bertino JS Jr, Greenberg HE, Reed MD. American College of Clinical Pharmacology. American College of Clinical Pharmacology position statement on the use of microdosing in the drug development process. J Clin Pharmacol. 2007;47:418-422.
10. Sarapa N. Exploratory IND: a new regulatory strategy for early clinical drug development in the United States. Ernst Schering Res Found Workshop. 2007;59: 151-163.
11. Medical imaging and drug development. U.S. Food and Drug Administration website. http://www.fda.gov/Drugs/DevelopmentApprovalProcess/DevelopmentResources/ucm092895.htm. Updated December 4, 2014. Accessed October 7, 2015.
12. Guidance for industry, investigators, and reviewers exploratory IND studies. U.S. Food and Drug Administration website. http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm078933.pdf. Accessed October 7, 2015.
13. Korb ML, Hartman YE, Kovar J, Zinn KR, Bland KI, Rosenthal EL. Use of monoclonal antibody-IRDye800CWbioconjugates in the resection of breast cancer. J Surg Res. 2014;188:119-128.
14. Warram JM, de Boer E, Sorace AG, et al. Antibody-based imaging strategies for cancer. Cancer Metastasis Rev. 2014;33:809-822.
15. Cohen R, Stammes MA, de Roos IH, Stigter-van Walsum M, Visser GW, van Dongen GA. Inert coupling of IRDye800CW to monoclonal antibodies for clinical optical imaging of tumor targets. EJNMMI Res. 2011;1:31-43.
16. PreMarket approval (PMA). U.S. Food and Drug Administration website. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMA/pma.cfm. Updated October 5, 2015. Accessed October 7, 2015.
17. 510(k) premarket submission. U.S. Food and Drug Administration website. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmnsimplesearch.cfm. Updated October 5, 2015. Accessed October 7, 2015.
18. Basaran D, Salman MC, Boyraz G, et al. Accuracy of intraoperative frozen section in the evaluation of patients with adnexal mass: retrospective analysis of 748 cases with multivariate regression analysis. Pathol Oncol Res. 2015;21:113-118.
19. Novita G, Filassi JR, Ruiz CA, et al. Evaluation of frozen-section analysis of surgical margins in the treatment of breast cancer. Eur J Gynaecol Oncol. 2012;33: 498-501.
20. Zinn KR, Korb M, Samuel S, et al. IND-directed safety and biodistribution study of intravenously injected cetuximab-IRDye800 in cynomolgus macaques. Mol Imaging Biol. 2015;17:49-57.